Observational studyFrontiers in immunology2022

Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs.

Jitka Smetanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.